Investment
Features
FeesSafety
Academy
More
Pluang+

JMWH token on XRP Ledger valued at $2.23B, boosting tokenized commodity market growth.

Protocol Fundamentals
06 Oct 2026
Tokenpost
View Source
Neutral
JMWH token on XRP Ledger valued at $2.23B, boosting tokenized commodity market growth.

The JMWH token, linked to electricity and operating on the XRP Ledger, had a listed value of $2.23 billion as of July 25, 2026. This significant valuation highlights the token's role in expanding the tokenized commodity market, which includes assets like gold, diamonds, and electricity. However, this figure reflects the listed value, not net inflows, and does not confirm that the XRP Ledger leads the entire tokenized commodity market or surpasses Ethereum in total value. The distinction between tokens that move beyond their issuing platform and those confined to one platform affects market comparisons.

JMWH token's listed value reached $2.23 billion as of July 25, 2026. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 07, 2026 00:03 WIB: out of 50 major cryptocurrencies, 24 rose and 25 fell. Notable movers include COTI at Rp244 with a 1-day change of -2.72%, ONE at Rp41 with 82% buy orders, and COMP at Rp439.415 with 70% buy orders.

More News

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...

Company Fundamentals
Neutral
33 minutes ago
Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...

Analyst Insights
Bullish
1 hour ago
Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...

Analyst Insights
Bullish
1 hour ago
Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...

Analyst Insights
Bullish
2 hours ago
$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App